secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pulmatrix, Inc. (PULM)
CIK:        0001574235
Form:       8-K
Filed at:   2025-04-10T23:59:59+00:00
Accession:  0001641172-25-003620
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 5.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pulmatrix and Cullgen amend merger agreement to one-step merger; Second Merger Sub removed
--------------------------------------------------------------------------------

- Amendment No. 1 dated April 7, 2025 changes transaction from two-step to one-step merger, eliminating Second Merger Sub.
- Clarifies fractional shares provision; Cullgen will survive as wholly owned subsidiary of Pulmatrix.
- Boards of both companies approved the amendment; all other terms of original November 13, 2024 agreement remain.
- Transaction remains subject to stockholder approval, regulatory clearances, and Nasdaq listing; consideration unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1574235/000164117225003620/0001641172-25-003620-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1574235/000164117225003620/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-003620

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer